Long-Term miR-669a Therapy Alleviates Chronic Dilated Cardiomyopathy in Dystrophic Mice
Dilated cardiomyopathy (DCM) is a leading cause of chronic morbidity and mortality in muscular dystrophy (MD) patients. Current pharmacological treatments are not yet able to counteract chronic myocardial wastage, thus novel therapies are being intensely explored. MicroRNAs have been implicated as f...
Gespeichert in:
| Veröffentlicht in: | Journal of the American Heart Association. Cardiovascular and Cerebrovascular Disease 2013, Vol.2 (4), p.1-10 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 10 |
|---|---|
| container_issue | 4 |
| container_start_page | 1 |
| container_title | Journal of the American Heart Association. Cardiovascular and Cerebrovascular Disease |
| container_volume | 2 |
| creator | Quattrocelli, Mattia Crippa, Stefania Montecchiani, Celeste Camps, Jordi Cornaglia, Antonia Icaro Boldrin, Luisa Morgan, Jennifer Calligaro, Alberto Casasco, Andrea Orlacchio, Aldo Gijsbers, Rik D'hooge, Jan Toelen, Jaan Janssens, Stefan Sampaolesi, Maurilio |
| description | Dilated cardiomyopathy (DCM) is a leading cause of chronic morbidity and mortality in muscular dystrophy (MD) patients. Current pharmacological treatments are not yet able to counteract chronic myocardial wastage, thus novel therapies are being intensely explored. MicroRNAs have been implicated as fine regulators of cardiomyopathic progression. Previously, miR-669a downregulation has been linked to the severe DCM progression displayed by Sgcb-null dystrophic mice. However, the impact of long-term overexpression of miR-669a on muscle structure and functionality of the dystrophic heart is yet unknown. |
| format | Article |
| fullrecord | <record><control><sourceid>kuleuven</sourceid><recordid>TN_cdi_kuleuven_dspace_123456789_413680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>123456789_413680</sourcerecordid><originalsourceid>FETCH-kuleuven_dspace_123456789_4136803</originalsourceid><addsrcrecordid>eNqVykELgjAcBfARBUn5HXbrEII6ne4YWnSoSwgdZei_XE0n24r89nno0LHe5b0HvwlyQj9KPMZSf_q158g15uaPoWFCYuag80F1V68A3eJWnDxKGcdFA5r3A95ICU_BLRicNVp1osK5kOOvccZ1LVQ7qJ7bZsCiw_lgrFZ9M6KjqGCJZhcuDbifXqDVbltke-_-kPB4QlfWpucVlEFIopgmKSujgNDUJ__I9W-ytC9L3ptNUSI</addsrcrecordid><sourcetype>Institutional Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Long-Term miR-669a Therapy Alleviates Chronic Dilated Cardiomyopathy in Dystrophic Mice</title><source>Lirias (KU Leuven Association)</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Quattrocelli, Mattia ; Crippa, Stefania ; Montecchiani, Celeste ; Camps, Jordi ; Cornaglia, Antonia Icaro ; Boldrin, Luisa ; Morgan, Jennifer ; Calligaro, Alberto ; Casasco, Andrea ; Orlacchio, Aldo ; Gijsbers, Rik ; D'hooge, Jan ; Toelen, Jaan ; Janssens, Stefan ; Sampaolesi, Maurilio</creator><creatorcontrib>Quattrocelli, Mattia ; Crippa, Stefania ; Montecchiani, Celeste ; Camps, Jordi ; Cornaglia, Antonia Icaro ; Boldrin, Luisa ; Morgan, Jennifer ; Calligaro, Alberto ; Casasco, Andrea ; Orlacchio, Aldo ; Gijsbers, Rik ; D'hooge, Jan ; Toelen, Jaan ; Janssens, Stefan ; Sampaolesi, Maurilio</creatorcontrib><description>Dilated cardiomyopathy (DCM) is a leading cause of chronic morbidity and mortality in muscular dystrophy (MD) patients. Current pharmacological treatments are not yet able to counteract chronic myocardial wastage, thus novel therapies are being intensely explored. MicroRNAs have been implicated as fine regulators of cardiomyopathic progression. Previously, miR-669a downregulation has been linked to the severe DCM progression displayed by Sgcb-null dystrophic mice. However, the impact of long-term overexpression of miR-669a on muscle structure and functionality of the dystrophic heart is yet unknown.</description><identifier>ISSN: 2047-9980</identifier><identifier>EISSN: 2047-9980</identifier><language>eng</language><publisher>Wiley-Blackwell Publishing, Inc</publisher><ispartof>Journal of the American Heart Association. Cardiovascular and Cerebrovascular Disease, 2013, Vol.2 (4), p.1-10</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,315,780,784,4024,27860</link.rule.ids></links><search><creatorcontrib>Quattrocelli, Mattia</creatorcontrib><creatorcontrib>Crippa, Stefania</creatorcontrib><creatorcontrib>Montecchiani, Celeste</creatorcontrib><creatorcontrib>Camps, Jordi</creatorcontrib><creatorcontrib>Cornaglia, Antonia Icaro</creatorcontrib><creatorcontrib>Boldrin, Luisa</creatorcontrib><creatorcontrib>Morgan, Jennifer</creatorcontrib><creatorcontrib>Calligaro, Alberto</creatorcontrib><creatorcontrib>Casasco, Andrea</creatorcontrib><creatorcontrib>Orlacchio, Aldo</creatorcontrib><creatorcontrib>Gijsbers, Rik</creatorcontrib><creatorcontrib>D'hooge, Jan</creatorcontrib><creatorcontrib>Toelen, Jaan</creatorcontrib><creatorcontrib>Janssens, Stefan</creatorcontrib><creatorcontrib>Sampaolesi, Maurilio</creatorcontrib><title>Long-Term miR-669a Therapy Alleviates Chronic Dilated Cardiomyopathy in Dystrophic Mice</title><title>Journal of the American Heart Association. Cardiovascular and Cerebrovascular Disease</title><description>Dilated cardiomyopathy (DCM) is a leading cause of chronic morbidity and mortality in muscular dystrophy (MD) patients. Current pharmacological treatments are not yet able to counteract chronic myocardial wastage, thus novel therapies are being intensely explored. MicroRNAs have been implicated as fine regulators of cardiomyopathic progression. Previously, miR-669a downregulation has been linked to the severe DCM progression displayed by Sgcb-null dystrophic mice. However, the impact of long-term overexpression of miR-669a on muscle structure and functionality of the dystrophic heart is yet unknown.</description><issn>2047-9980</issn><issn>2047-9980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>FZOIL</sourceid><recordid>eNqVykELgjAcBfARBUn5HXbrEII6ne4YWnSoSwgdZei_XE0n24r89nno0LHe5b0HvwlyQj9KPMZSf_q158g15uaPoWFCYuag80F1V68A3eJWnDxKGcdFA5r3A95ICU_BLRicNVp1osK5kOOvccZ1LVQ7qJ7bZsCiw_lgrFZ9M6KjqGCJZhcuDbifXqDVbltke-_-kPB4QlfWpucVlEFIopgmKSujgNDUJ__I9W-ytC9L3ptNUSI</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Quattrocelli, Mattia</creator><creator>Crippa, Stefania</creator><creator>Montecchiani, Celeste</creator><creator>Camps, Jordi</creator><creator>Cornaglia, Antonia Icaro</creator><creator>Boldrin, Luisa</creator><creator>Morgan, Jennifer</creator><creator>Calligaro, Alberto</creator><creator>Casasco, Andrea</creator><creator>Orlacchio, Aldo</creator><creator>Gijsbers, Rik</creator><creator>D'hooge, Jan</creator><creator>Toelen, Jaan</creator><creator>Janssens, Stefan</creator><creator>Sampaolesi, Maurilio</creator><general>Wiley-Blackwell Publishing, Inc</general><scope>FZOIL</scope></search><sort><creationdate>2013</creationdate><title>Long-Term miR-669a Therapy Alleviates Chronic Dilated Cardiomyopathy in Dystrophic Mice</title><author>Quattrocelli, Mattia ; Crippa, Stefania ; Montecchiani, Celeste ; Camps, Jordi ; Cornaglia, Antonia Icaro ; Boldrin, Luisa ; Morgan, Jennifer ; Calligaro, Alberto ; Casasco, Andrea ; Orlacchio, Aldo ; Gijsbers, Rik ; D'hooge, Jan ; Toelen, Jaan ; Janssens, Stefan ; Sampaolesi, Maurilio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kuleuven_dspace_123456789_4136803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quattrocelli, Mattia</creatorcontrib><creatorcontrib>Crippa, Stefania</creatorcontrib><creatorcontrib>Montecchiani, Celeste</creatorcontrib><creatorcontrib>Camps, Jordi</creatorcontrib><creatorcontrib>Cornaglia, Antonia Icaro</creatorcontrib><creatorcontrib>Boldrin, Luisa</creatorcontrib><creatorcontrib>Morgan, Jennifer</creatorcontrib><creatorcontrib>Calligaro, Alberto</creatorcontrib><creatorcontrib>Casasco, Andrea</creatorcontrib><creatorcontrib>Orlacchio, Aldo</creatorcontrib><creatorcontrib>Gijsbers, Rik</creatorcontrib><creatorcontrib>D'hooge, Jan</creatorcontrib><creatorcontrib>Toelen, Jaan</creatorcontrib><creatorcontrib>Janssens, Stefan</creatorcontrib><creatorcontrib>Sampaolesi, Maurilio</creatorcontrib><collection>Lirias (KU Leuven Association)</collection><jtitle>Journal of the American Heart Association. Cardiovascular and Cerebrovascular Disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quattrocelli, Mattia</au><au>Crippa, Stefania</au><au>Montecchiani, Celeste</au><au>Camps, Jordi</au><au>Cornaglia, Antonia Icaro</au><au>Boldrin, Luisa</au><au>Morgan, Jennifer</au><au>Calligaro, Alberto</au><au>Casasco, Andrea</au><au>Orlacchio, Aldo</au><au>Gijsbers, Rik</au><au>D'hooge, Jan</au><au>Toelen, Jaan</au><au>Janssens, Stefan</au><au>Sampaolesi, Maurilio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-Term miR-669a Therapy Alleviates Chronic Dilated Cardiomyopathy in Dystrophic Mice</atitle><jtitle>Journal of the American Heart Association. Cardiovascular and Cerebrovascular Disease</jtitle><date>2013</date><risdate>2013</risdate><volume>2</volume><issue>4</issue><spage>1</spage><epage>10</epage><pages>1-10</pages><issn>2047-9980</issn><eissn>2047-9980</eissn><abstract>Dilated cardiomyopathy (DCM) is a leading cause of chronic morbidity and mortality in muscular dystrophy (MD) patients. Current pharmacological treatments are not yet able to counteract chronic myocardial wastage, thus novel therapies are being intensely explored. MicroRNAs have been implicated as fine regulators of cardiomyopathic progression. Previously, miR-669a downregulation has been linked to the severe DCM progression displayed by Sgcb-null dystrophic mice. However, the impact of long-term overexpression of miR-669a on muscle structure and functionality of the dystrophic heart is yet unknown.</abstract><pub>Wiley-Blackwell Publishing, Inc</pub><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2047-9980 |
| ispartof | Journal of the American Heart Association. Cardiovascular and Cerebrovascular Disease, 2013, Vol.2 (4), p.1-10 |
| issn | 2047-9980 2047-9980 |
| language | eng |
| recordid | cdi_kuleuven_dspace_123456789_413680 |
| source | Lirias (KU Leuven Association); DOAJ Directory of Open Access Journals; Wiley Online Library Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| title | Long-Term miR-669a Therapy Alleviates Chronic Dilated Cardiomyopathy in Dystrophic Mice |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T12%3A08%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kuleuven&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-Term%20miR-669a%20Therapy%20Alleviates%20Chronic%20Dilated%20Cardiomyopathy%20in%20Dystrophic%20Mice&rft.jtitle=Journal%20of%20the%20American%20Heart%20Association.%20Cardiovascular%20and%20Cerebrovascular%20Disease&rft.au=Quattrocelli,%20Mattia&rft.date=2013&rft.volume=2&rft.issue=4&rft.spage=1&rft.epage=10&rft.pages=1-10&rft.issn=2047-9980&rft.eissn=2047-9980&rft_id=info:doi/&rft_dat=%3Ckuleuven%3E123456789_413680%3C/kuleuven%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |